Quick Search 
Drugs of Today
Register or sign in

Drugs Today 2009, 45(9): 663
ISSN 1699-3993
e-ISSN 1699-4019
Copyright 2009 Clarivate
CCC: 1699-3993
DOI: 10.1358/dot.2009.45.9.1399952
Rotigotine for restless legs syndrome
Davies, S.
Restless legs syndrome (RLS) is a neurological disorder related to abnormal and unpleasant sensations and movements in the legs. It usually occurs at nighttime and thus has a detrimental impact on the ability to sleep, leading to poor patient quality of life. UCB has been developing rotigotine transdermal patch system (Neupro®; SPM-962) as a treatment for RLS. This system is designed to replace levels of dopamine in the body via once-daily application of the patch, in a bid to restore proper motor functioning. The rotigotine patch has been authorized for the treatment of RLS since August 2008.

Full Text: HTMLPDF 

© Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences